News Daily News ASCVD and Cancer Diagnoses Pose Potentially Deadly Costs to Patients Caitlin E. Cox June 16, 2021
News Conference News EAS 2020 Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention Michael O'Riordan October 08, 2020
News Daily News ADHD Drug Overprescribing Raises Concerns Over Future CV Events L.A. McKeown August 11, 2020
News Conference News EuroPCR 2020 Cardiac Arrests Have Soared Worldwide: How Was COVID-19 to Blame? Shelley Wood June 29, 2020
News Daily News Dose of Reality? Hydroxychloroquine and Chloroquine Again Disappoint in COVID-19 Michael O'Riordan May 26, 2020
News Conference News ACC 2020 Pooled Inclisiran Data: Safe LDL-Lowering, Plus Hints of Fewer CVD Events Michael O'Riordan April 02, 2020
News Daily News New Review Tracks ‘Evolving’ CV Impact of COVID-19 on Patients, Hospitals Michael O'Riordan March 20, 2020
News Daily News Nearly Half of Diabetic Patients Struggle to Pay Medical Bills Michael O'Riordan February 12, 2020
News Daily News Exposure to Air Pollution in China Tied to Increase in Coronary Calcium Todd Neale June 28, 2019
News Conference News EAS 2019 Inclisiran Safe and Effective in Patients With Impaired Renal Function: ORION Michael O'Riordan June 04, 2019
News Daily News Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks Michael O'Riordan April 10, 2019
News Conference News AHA 2018 Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT Michael O'Riordan November 10, 2018
News Conference News AHA 2018 REDUCE-IT: Prescription Fish Oil Prevents CV Events in Patients With High Triglycerides Todd Neale November 10, 2018
News Daily News Big Fitness Equals Big Survival Benefit, New Study Shows Michael O'Riordan October 22, 2018
News Daily News No Benefits, Higher Costs With IVC Filters in Catheter-Directed Thrombolysis for DVT Michael O'Riordan July 23, 2018
News Conference News ESC 2017 Less Is More? Health Benefits of Fruits, Vegetables, and Legumes Seen at Lower Intake Levels Michael O'Riordan August 29, 2017
News Conference News ESC 2017 CANTOS: Anti-inflammatory Agent Canakinumab Modestly Reduces Major CVD Events Michael O'Riordan August 27, 2017